Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Food Effect Projections via Physiologically Based Pharmacokinetic Modeling: Predictive Case Studies
Christophe Tistaert, Tycho Heimbach, Binfeng Xia, et al.
Journal of Pharmaceutical Sciences (2018) Vol. 108, Iss. 1, pp. 592-602
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 147, pp. 105280-105280
Open Access | Times Cited: 219
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Zahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 289-331
Open Access | Times Cited: 114
Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity
Lu Gaohua, Xiu‐Sheng Miao, Dou Liu
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 9, pp. 1103-1124
Open Access | Times Cited: 106
The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines
Aggelos Charalabidis, Maria Sfouni, Christel A. S. Bergström, et al.
International Journal of Pharmaceutics (2019) Vol. 566, pp. 264-281
Closed Access | Times Cited: 137
Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies
Neil A. Miller, Micaela B. Reddy, Aki T. Heikkinen, et al.
Clinical Pharmacokinetics (2019) Vol. 58, Iss. 6, pp. 727-746
Open Access | Times Cited: 111
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
Arian Emami Riedmaier, Kevin DeMent, James E. Huckle, et al.
The AAPS Journal (2020) Vol. 22, Iss. 6
Open Access | Times Cited: 74
Applications of PBPK/PBBM modeling in generic product development: An industry perspective
K Yuvaneshwari, Sivacharan Kollipara, Tausif Ahmed, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 69, pp. 103152-103152
Closed Access | Times Cited: 41
Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs
Karine Rodríguez-Fernández, José David Gómez‐Mantilla, Suneet Shukla, et al.
Clinical Pharmacokinetics (2025)
Open Access | Times Cited: 1
The impact of food intake on the luminal environment and performance of oral drug products with a view toin vitroandin silicosimulations: a PEARRL review
Christina Pentafragka, Mira Symillides, Mark McAllister, et al.
Journal of Pharmacy and Pharmacology (2018) Vol. 71, Iss. 4, pp. 557-580
Open Access | Times Cited: 61
Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them
Sheila Annie Peters, Hugues Dolgos
Clinical Pharmacokinetics (2019) Vol. 58, Iss. 11, pp. 1355-1371
Open Access | Times Cited: 61
Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review
Joseph P. O’Shea, Patrick Augustijns, Martin Brandl, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 170, pp. 106098-106098
Open Access | Times Cited: 51
Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report
Xavier Pépin, Neil Parrott, Jennifer B. Dressman, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 2, pp. 555-566
Closed Access | Times Cited: 50
Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the U.S. Food and Drug Administration for New Drugs
Fang Wu, Heta Shah, Min Li, et al.
The AAPS Journal (2021) Vol. 23, Iss. 2
Closed Access | Times Cited: 50
The Impact of Diet and Exercise on Drug Responses
Ellen Niederberger, Michael J. Parnham
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7692-7692
Open Access | Times Cited: 50
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentary
Masoud Jamei, Bertil Abrahamsson, Jonathan Brown, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 155, pp. 55-68
Closed Access | Times Cited: 48
Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies
Amitava Mitra, Neil Parrott, Neil A. Miller, et al.
Journal of Pharmaceutical Sciences (2019) Vol. 109, Iss. 3, pp. 1380-1394
Closed Access | Times Cited: 47
Physiologically Based Absorption Modelling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of Entrectinib
Neil Parrott, Cordula Stillhart, Marc Lindenberg, et al.
The AAPS Journal (2020) Vol. 22, Iss. 4
Open Access | Times Cited: 42
Assessment of food effects during clinical development
Zahari Vinarov, James Butler, Filippos Kesisoglou, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122758-122758
Open Access | Times Cited: 15
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview
Andrew Babiskin, Fang Wu, Youssef M. Mousa, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 5, pp. 619-623
Open Access | Times Cited: 13
Physiologically Based Pharmacokinetic (PBPK) Modeling of small molecules: How Much Progress Have We Made?
Nina Isoherranen
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 1, pp. 100013-100013
Open Access | Times Cited: 5
Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach
Xavier Pépin, James E. Huckle, Ravindra V. Alluri, et al.
The AAPS Journal (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 30
Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms
Timothy R. Lex, Jason D. Rodriguez, Lei Zhang, et al.
The AAPS Journal (2022) Vol. 24, Iss. 2
Closed Access | Times Cited: 21
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report
Abdullah Al Shoyaib, Arian Emami Riedmaier, Anita Kumar, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 5, pp. 610-618
Open Access | Times Cited: 12
Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives
Sivacharan Kollipara, Frederico Severino Martins, Maitri Sanghavi, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 2, pp. 345-358
Closed Access | Times Cited: 12
Formulation Strategy of BCS-II Drugs by Coupling Mechanistic In-Vitro and Nonclinical In-Vivo Data with PBPK: Fundamentals of Absorption-Dissolution to Parameterization of Modelling and Simulation
V A Shriya, Usha Y. Nayak, Muddukrishna Badamane Sathyanarayana, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 5
Open Access
Page 1 - Next Page

Scroll to top